Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Antihypertensive effects of SGLT2 inhibitors in type 2 diabetes.
Muskiet MHA, van Bommel EJ, van Raalte DH. Muskiet MHA, et al. Among authors: van bommel ej, van raalte dh. Lancet Diabetes Endocrinol. 2016 Mar;4(3):188-189. doi: 10.1016/S2213-8587(15)00457-X. Epub 2015 Nov 25. Lancet Diabetes Endocrinol. 2016. PMID: 26620250 No abstract available.
Understanding EMPA-REG OUTCOME.
Muskiet MH, van Raalte DH, van Bommel EJ, Smits MM, Tonneijck L. Muskiet MH, et al. Among authors: van bommel ej, van raalte dh. Lancet Diabetes Endocrinol. 2015 Dec;3(12):928-9. doi: 10.1016/S2213-8587(15)00424-6. Lancet Diabetes Endocrinol. 2015. PMID: 26590679 No abstract available.
Renoprotection in LEADER and EMPA-REG OUTCOME.
Muskiet MH, Tonneijck L, van Bommel EJ, Smits MM, van Raalte DH. Muskiet MH, et al. Among authors: van bommel ej, van raalte dh. Lancet Diabetes Endocrinol. 2016 Oct;4(10):812-4. doi: 10.1016/S2213-8587(16)30214-5. Lancet Diabetes Endocrinol. 2016. PMID: 27663955 No abstract available.
The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial.
van Bommel EJM, Muskiet MHA, van Baar MJB, Tonneijck L, Smits MM, Emanuel AL, Bozovic A, Danser AHJ, Geurts F, Hoorn EJ, Touw DJ, Larsen EL, Poulsen HE, Kramer MHH, Nieuwdorp M, Joles JA, van Raalte DH. van Bommel EJM, et al. Among authors: van baar mjb, van raalte dh. Kidney Int. 2020 Jan;97(1):202-212. doi: 10.1016/j.kint.2019.09.013. Epub 2019 Oct 10. Kidney Int. 2020. PMID: 31791665 Free article. Clinical Trial.
The effect of dapagliflozin on apolipoprotein B and glucose fluxes in patients with type 2 diabetes and well-controlled plasma LDL cholesterol.
Bouter KEC, van Bommel EJM, Jansen H, van Harskamp D, Schierbeek H, Ackermans MT, Serlie MJ, Schimmel AWM, Nieuwdorp M, Dallinga-Thie GM, van Raalte DH. Bouter KEC, et al. Diabetes Obes Metab. 2020 Jun;22(6):988-996. doi: 10.1111/dom.13990. Epub 2020 Feb 27. Diabetes Obes Metab. 2020. PMID: 32026592 Free PMC article.
24 results